Clin2
NCT05030805Possibly a fitRecruiting

Study maps ovarian cancer cells from surgical tissue

Ovarian Cancer

Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You are a woman age 18 or older
  • You have ovarian cancer confirmed by pathology (lab tissue diagnosis)
  • You had gynecology surgery at Strasbourg University Hospital between 2021 and 2024
  • You agreed to join the study and to store/use your biological samples
  • You are not pregnant and you are not breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03943316Recruiting
Testing new cancer treatments on cells from ovarian cancer fluid

This laboratory study uses ovarian cancer fluid collected during surgery to test possible new treatments on cancer and immune cells. It may help researchers find better treatment options in ovarian cancer.

Albuquerque, New Mexico
NCT06071286Recruiting
Study tracking DNA from tumors in advanced ovarian cancer

This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.

Roma
NCT05251883Recruiting
Study of data from metastatic ovarian cancer using multiple tests

This study looks at metastatic ovarian cancer by analyzing many types of patient data (from “multi-omics,” which means different kinds of lab and biological information). It may help doctors better understand the disease and improve future care.

Guangzhou, Guangdong
NCT06229522Recruiting
Organoids to personalize ovarian cancer treatment

This study uses lab-grown tumor models (organoids) from your tissue or fluid sample to find the best treatment for your ovarian cancer.

Aviano, Pordenone
NCT03010124Recruiting
Biomarker testing in ovarian cancer to guide future treatment

This study looks at tumor tissue from ovarian cancer patients to find “biomarkers,” or lab signals, that may predict how the disease behaves or how it might respond to treatment. You may be asked for a biopsy of the relapsed (coming back) tumor or to use an existing archived tumor sample.

Villejuif, Val de Marne
NCT00005095Recruiting
Ovarian cancer risk study: specimens and health data

This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.

Chicago, Illinois

Hear when a new Ovarian cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.